Diarrhea associated with inflammatory bowel diseases (IBD) or infections by food-borne pathogens remains a major health problem in our veteran patient population. Despite major medical advances, diarrheal diseases still result in very high morbidity and mortality worldwide. Therefore, a better understanding of the pathophysiology of diarrhea associated with these diseases is critical for designing novel and superior strategies for intervention. Diarrhea results from increased intestinal secretion and/or decreased absorption. A major route of electrolyte absorption in the human intestine involves coupled operation of Na+/H+ and Cl-/HCO3- exchangers. The gene Slc26a3, whose mutations are associated with congenital chloride diarrhea, encodes DRA (Down-Regulated in Adenoma), a protein known to play a critical role in mediating intestinal chloride absorption. Recently, significant reduction of DRA expression has been shown to be one of the major mechanisms responsible for diarrhea in IBD patients. To date, however, very little is known about the molecular mechanisms involved in decreasing DRA expression in diarrheal diseases. In order to elucidate the mechanisms underlying the downregulation of DRA expression in IBD, our studies focused on the role of hepatic nuclear factors (HNFs, transcription factors essential for the expression of many transport proteins) and miRNAs (known to be upregulated in IBD patients and animal models of IBD). Our extensive preliminary data provided strong evidence for the regulation of DRA expression by both HNFs and their activators dexamenthasone (DEX) and conjugated linoleic acids (CLAs), as well as miRNAs. Based on these data, we hypothesize that a down-regulation of HNFs and upregulation of certain miRNAs in inflamed gut may underlie the decrease in DRA expression via transcriptional and post-transcriptional mechanisms, respectively. The current application is, therefore, designed to investigate the regulation of DRA by HNFs and miRNAs utilizing both in vitro (Aims 1 &2) and in vivo models (Aim 3) as follows:
Aim 1. Elucidate detailed mechanisms underlying basal regulation of DRA promoter by HNFs, in decreased DRA expression in IBD and to establish the molecular basis for the upregulation of DRA by DEX and CLAs;
Aim 2 : Extensively analyze the mechanisms underlying post-transcriptional regulation of DRA by miRNAs;
and Aim 3 : Analyze the regulation of DRA by HNFs and miRs in wild type and IL-10 knock out mouse model for IBD. The outcome of these studies should define the role of HNFs in basal, inflammatory or CLA/DEX-mediated upregulation of DRA, and will also establish for the first time, the role of miRs in the modulation of intestinal NaCl absorption under normal and inflammatory conditions. These studies should also identify novel targets for intervention in IBD associated diarrhea.
Diarrhea associated with inflammatory bowel diseases (IBD) and food-borne bacterial infections is a major health care problem in our veterans. Therefore, an understanding of the mechanisms of diarrheal diseases is extremely important for developing novel and superior drugs. The proposed studies are focused at understanding the mechanisms of a decrease in the levels of the key transporter involved in chloride absorption in the intestine in models of intestinal inflammation. The molecular biology approaches outlined in this application are likely to increase our knowledge of regulation of this transporter and identify novel targets for therapies of diarrheal diseases and IBD.
|Jayawardena, Dulari; Guzman, Grace; Gill, Ravinder K et al. (2017) Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine. Am J Physiol Gastrointest Liver Physiol 313:G16-G25|
|Anbazhagan, Arivarasu N; Thaqi, Mentor; Priyamvada, Shubha et al. (2017) GLP-1 nanomedicine alleviates gut inflammation. Nanomedicine 13:659-665|
|Anabazhagan, Arivarasu N; Chatterjee, Ishita; Priyamvada, Shubha et al. (2017) Methods to Study Epithelial Transport Protein Function and Expression in Native Intestine and Caco-2 Cells Grown in 3D. J Vis Exp :|
|Chatterjee, Ishita; Kumar, Anoop; Castilla-Madrigal, Rosa María et al. (2017) CDX2 upregulates SLC26A3 gene expression in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 313:G256-G264|
|Singhal, Megha; Manzella, Christopher; Soni, Vinay et al. (2017) Role of SHP2 protein tyrosine phosphatase in SERT inhibition by enteropathogenic E. coli (EPEC). Am J Physiol Gastrointest Liver Physiol 312:G443-G449|
|Malhotra, Pooja; Aloman, Costica; Ankireddy, Aparna et al. (2017) Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 313:G376-G385|
|Kumar, Anoop; Chatterjee, Ishita; Gujral, Tarunmeet et al. (2017) Activation of Nuclear Factor-?B by Tumor Necrosis Factor in Intestinal Epithelial Cells and Mouse Intestinal Epithelia Reduces Expression of the Chloride Transporter SLC26A3. Gastroenterology 153:1338-1350.e3|
|Gujral, Tarunmeet; Kumar, Anoop; Priyamvada, Shubha et al. (2015) Mechanisms of DRA recycling in intestinal epithelial cells: effect of enteropathogenic E. coli. Am J Physiol Cell Physiol 309:C835-46|
|Priyamvada, Shubha; Gomes, Rochelle; Gill, Ravinder K et al. (2015) Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea. Inflamm Bowel Dis 21:2926-35|
|Muthusamy, Saminathan; Malhotra, Pooja; Hosameddin, Mobashir et al. (2015) N-glycosylation is essential for ileal ASBT function and protection against proteases. Am J Physiol Cell Physiol 308:C964-71|
Showing the most recent 10 out of 13 publications